Home › High Blood Pressure › Nebraska › Omaha
High Blood Pressure clinical trials in Omaha, NE
4 studies for High Blood Pressure are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Quality Clinical Research - Omaha, Omaha
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Omaha
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
RecruitingPhase 4
- Methodist Women's Hospital, Omaha
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
RecruitingPhase 4
- Nebraska Methodist Women's Hospital, Omaha
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL22 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Tucson, AZ10 studies
- Atlanta, GA10 studies
- Durham, NC10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.